For research use only. Not for therapeutic Use.
Indolmycin is an antibiotic produced by certain Streptomyces species, known for its selective inhibition of bacterial tryptophanyl-tRNA synthetase, an enzyme crucial for protein synthesis. This mode of action makes indolmycin particularly effective against a range of Gram-positive bacteria and some Gram-negative bacteria, including Helicobacter pylori. Due to its unique mechanism, indolmycin has been studied as a potential therapeutic agent for treating bacterial infections, especially those resistant to other antibiotics. Its specificity also makes it a valuable tool in research for studying protein synthesis and bacterial biology.
Catalog Number | R005170 |
CAS Number | 21200-24-8 |
Synonyms | 5S-[(1R)-1-(1H-indol-3-yl)ethyl]-2-(methylamino)-4(5H)-oxazolone |
Molecular Formula | C14H15N3O2 |
Purity | ≥95% |
Target | Antibiotic |
Solubility | Soluble in ethanol, methanol, DMF or DMSO. Poor water solubility. |
Storage | -20°C |
IUPAC Name | (5S)-5-[(1R)-1-(1H-indol-3-yl)ethyl]-2-(methylamino)-1,3-oxazol-4-one |
InChI | InChI=1S/C14H15N3O2/c1-8(12-13(18)17-14(15-2)19-12)10-7-16-11-6-4-3-5-9(10)11/h3-8,12,16H,1-2H3,(H,15,17,18)/t8-,12+/m1/s1 |
InChIKey | GNTVWGDQPXCYBV-PELKAZGASA-N |
SMILES | CC(C1C(=O)N=C(O1)NC)C2=CNC3=CC=CC=C32 |